Approach
We partner with breakthrough medical device founders at the earliest stage, seed and Series A, providing long-term capital and active support to build enduring companies that measurably improve patient outcomes.
Our Investment Focus
Clinical Impact & Evidence: Breakthrough technologies that measurably improve patient outcomes, backed by a clinical strategy designed to generate meaningful evidence.
MedTech Focus & Market Potential: Medical devices are our core focus, centered on large market opportunities where innovation can scale rapidly.
Early-Stage Partnership: Seed and Series A focus, supporting founders from first check through exit.
Founder-Market Fit: Teams with deep domain insight and the relationships to navigate healthcare's clinical, regulatory, and commercial complexities.
Defensible IP & Economics: Compelling value for all stakeholders, backed by defensible technology and a clear path to attractive unit economics.
Regulatory & Reimbursement Clarity: Primarily 510(k) and De Novo pathways, with established or attainable reimbursement strategies.
Focused involvement where our experience is most valuable
Support on clinical strategy, trial design, and evidence generation
Guidance on regulatory and reimbursement pathways and key milestones
Introductions to KOLs, strategic partners, and downstream investors
Active help with syndicate building and preparation for follow-on rounds
How We Work With Companies
Long-Term Partnership Mindset
Investing with the intent to be a lasting partner, not a transient source of capital
Respecting the clinical, technical, and commercial rigor required to bring safe, effective medical technologies to patients
Aligning our every decision with durable, measurable improvements in patient outcomes
NeoPrima Ventures®
Partner with us to advance MedTech innovation and improve patient outcomes.